In episode 550, James and Mike talk in a PREMIUM way about a new cholesterol lowering agent. Bempedoic acid is nothing tremendously exciting but what was very interesting was a subsequent publication that looked at a primary subset analysis, yet completely left out the secondary subset data. Have a listen and find out why.

Show Notes

Sensible Medicine
Lipid lowering – a Bempedoic Acid Subset Analysis – To be right, you have to also look at what is left

MyStudies

CFPC Learn

PEIP conference Oct 20-21, 2023

In episode 549, James and Mike invite Blair MacDonald to the podcast for the first time and we talk about a topic that we haven’t really covered to-date. We discuss the evidence around what happens to the risk of pancreatitis when we use triglyceride-lowering medications (fibrates, statins, niacin, omega-3s) in patients with hypertriglyceridemia. Have a listen as the results may surprise you somewhat.

Show Notes

Tools for Practice

Triglyce-Ride that High?

CFPC Learn

PEIP conference Oct 20-21 2023

In episode 548, James and Mike invite Betsy Thomas back to the podcast to talk about whether or not measuring lipoprotein(a) or apolipoprotein B improves cardiovascular risk prediction in a meaningful way over and above using standard risk factors. Many guidelines are now recommending we should do these measurements but is this an evidence-based recommendation? Give us 30 minutes of your time and you’ll know the answer.

Show Notes

Less is More Unless it’s Sleep or Toilet Paper: Non-traditional lipoproteins for cardiovascular risk
Tools for Practice

CFPC Learn

PEIP conference Oct 20-21 2023